Nurexone Biologic Inc
Nurexone Biologic Inc., traded on the TSXV, OTCQB, and Frankfurt exchanges, is focused on regenerative exosome-based therapies for central nervous system injuries. CEO Lior Shaltiel explains the company's research on its lead candidate, XOP10.